PT Sariguna Primatirta Tbk (IDX: CLEO)
Indonesia
· Delayed Price · Currency is IDR
1,245.00
+40.00 (3.32%)
Dec 3, 2024, 4:06 PM WIB
CLEO Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 2,564,067 | 2,090,116 | 1,674,054 | 1,103,520 | 972,635 | 1,084,913 | Upgrade
|
Revenue Growth (YoY) | 18.52% | 24.85% | 51.70% | 13.46% | -10.35% | 30.54% | Upgrade
|
Cost of Revenue | 1,083,013 | 930,648 | 848,619 | 647,894 | 569,182 | 699,446 | Upgrade
|
Gross Profit | 1,481,054 | 1,159,468 | 825,435 | 455,626 | 403,453 | 385,466 | Upgrade
|
Selling, General & Admin | 854,668 | 709,146 | 520,392 | 192,925 | 189,372 | 178,242 | Upgrade
|
Other Operating Expenses | 1,994 | 3,701 | 3,084 | 1,093 | 1,057 | 1,455 | Upgrade
|
Operating Expenses | 856,662 | 712,847 | 523,476 | 194,018 | 190,429 | 179,698 | Upgrade
|
Operating Income | 624,393 | 446,620 | 301,958 | 261,608 | 213,024 | 205,769 | Upgrade
|
Interest Expense | -25,532 | -19,322 | -14,331 | -13,524 | -25,248 | -14,564 | Upgrade
|
Currency Exchange Gain (Loss) | 6,836 | 2,606 | 2,981 | 422.59 | 1,031 | -1,531 | Upgrade
|
Other Non Operating Income (Expenses) | 1,557 | 3,427 | -1,643 | 4,508 | -1,478 | -3,358 | Upgrade
|
EBT Excluding Unusual Items | 607,254 | 433,331 | 288,964 | 253,015 | 187,329 | 186,316 | Upgrade
|
Gain (Loss) on Sale of Assets | -32,228 | -20,740 | -38,105 | -22,672 | -18,365 | -13,648 | Upgrade
|
Pretax Income | 575,026 | 412,591 | 250,859 | 230,343 | 168,965 | 172,668 | Upgrade
|
Income Tax Expense | 123,669 | 88,498 | 55,393 | 49,632 | 36,192 | 41,911 | Upgrade
|
Earnings From Continuing Operations | 451,357 | 324,092 | 195,466 | 180,712 | 132,772 | 130,756 | Upgrade
|
Minority Interest in Earnings | -5,637 | -100.7 | - | - | - | 0.1 | Upgrade
|
Net Income | 445,720 | 323,991 | 195,466 | 180,712 | 132,772 | 130,757 | Upgrade
|
Net Income to Common | 445,720 | 323,991 | 195,466 | 180,712 | 132,772 | 130,757 | Upgrade
|
Net Income Growth | 75.65% | 65.75% | 8.16% | 36.11% | 1.54% | 106.69% | Upgrade
|
Shares Outstanding (Basic) | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | Upgrade
|
Shares Outstanding (Diluted) | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | Upgrade
|
Shares Change (YoY) | - | - | - | - | - | 7.83% | Upgrade
|
EPS (Basic) | 37.14 | 27.00 | 16.29 | 15.06 | 11.06 | 10.90 | Upgrade
|
EPS (Diluted) | 37.14 | 27.00 | 16.29 | 15.06 | 11.06 | 10.90 | Upgrade
|
EPS Growth | 75.65% | 65.75% | 8.16% | 36.11% | 1.54% | 91.68% | Upgrade
|
Free Cash Flow | -18,802 | 123,851 | -91,612 | 146,764 | 54,472 | -235,450 | Upgrade
|
Free Cash Flow Per Share | -1.57 | 10.32 | -7.63 | 12.23 | 4.54 | -19.62 | Upgrade
|
Dividend Per Share | 5.050 | 5.050 | 1.650 | 3.500 | 2.500 | - | Upgrade
|
Dividend Growth | 206.06% | 206.06% | -52.86% | 40.00% | - | - | Upgrade
|
Gross Margin | 57.76% | 55.47% | 49.31% | 41.29% | 41.48% | 35.53% | Upgrade
|
Operating Margin | 24.35% | 21.37% | 18.04% | 23.71% | 21.90% | 18.97% | Upgrade
|
Profit Margin | 17.38% | 15.50% | 11.68% | 16.38% | 13.65% | 12.05% | Upgrade
|
Free Cash Flow Margin | -0.73% | 5.93% | -5.47% | 13.30% | 5.60% | -21.70% | Upgrade
|
EBITDA | 816,020 | 613,925 | 430,988 | 351,583 | 294,631 | 263,246 | Upgrade
|
EBITDA Margin | 31.83% | 29.37% | 25.75% | 31.86% | 30.29% | 24.26% | Upgrade
|
D&A For EBITDA | 191,627 | 167,305 | 129,029 | 89,974 | 81,607 | 57,477 | Upgrade
|
EBIT | 624,393 | 446,620 | 301,958 | 261,608 | 213,024 | 205,769 | Upgrade
|
EBIT Margin | 24.35% | 21.37% | 18.04% | 23.71% | 21.90% | 18.97% | Upgrade
|
Effective Tax Rate | 21.51% | 21.45% | 22.08% | 21.55% | 21.42% | 24.27% | Upgrade
|
Advertising Expenses | - | 68,377 | 44,933 | 42,050 | 39,042 | 34,951 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.